Eupraxia Pharmaceuticals Announces Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI ...
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology ...
Medscape3 小时
Low Vitamin D Levels at 3 Years of Age Linked to Higher Asthma Risk
Deficiency of 25-hydroxyvitamin D at age 3 years is associated with more than double the risk for eosinophilic asthma in ...